Therefore, colon adenocarcinoma cells by downregulation of ACKR2 promote chronic inflammation and an immunosuppressive microenvironment to facilitate evasion of tumor cells from potent immune responses, suggesting ACKR2 as a potential biomarker for analyzing the development of colon adenocarcinoma. The gene discussed is ACKR2; the disease is neoplasm.